Head-to-Head

Halozyme Therapeutics, Inc. vs. Sutro Biopharma, Inc.

HALO

Halozyme Therapeutics, Inc.

$95.58 -0.95%

VS STRO

Sutro Biopharma, Inc.

$8.92 -4.29%

Halozyme Therapeutics, Inc. and Sutro Biopharma, Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

HALOSTRO
Market Cap $11.00 billion $154.73 million

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOSTRO
Short Interest 9.75% 0.07%

STRO leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, STRO overview, STRO financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.